tiprankstipranks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
US Market
MNPR
Monopar Therapeutics Inc
RESEARCH TOOLSreports

Monopar Therapeutics Inc (MNPR) Income Statement

571 Followers

Monopar Therapeutics Inc Income Statement

Last quarter (Q4 2025), Monopar Therapeutics Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Monopar Therapeutics Inc's net income was $-5.20M. See Monopar Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 16.70M$ 16.16M$ 8.83M$ 10.54M$ 9.13M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -16.70M$ -16.16M$ -8.83M$ -10.54M$ -9.13M
Operating Income
$ -16.70M$ -16.16M$ -8.83M$ -10.54M$ -9.13M
Other Income/Expenses
$ 2.99M$ 575.30K$ 429.04K$ 21.24K$ 24.02K
Pretax Income
$ -13.72M$ -15.59M$ -8.40M$ -10.52M$ -9.10M
Net Income
$ -13.72M$ -15.59M$ -8.40M$ -10.52M$ -9.10M
Per Share Metrics
Basic EPS
$ -1.85$ -1.36$ -0.58$ -0.83$ -0.73
Diluted EPS
$ -1.85$ -1.36$ -0.58$ -0.83$ -0.73
Weighted Average Shares Outstanding
 7.41M 11.44M 14.51M 12.72M 12.47M
Weighted Average Shares Outstanding (Diluted)
 7.41M 11.48M 14.51M 12.72M 12.47M
Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History